乌鸦传媒

<乌鸦传媒 class='mpt-top_cat_title'>Cardiology >

Hypertension

News, opinions and meeting coverage in cardiology.

<乌鸦传媒>Bariatric Surgery Improves Metabolic Syndrome for PCOS

Small cohort with obesity and PCOS saw improvement

<乌鸦传媒>The American Heart Association's Stance Against Science

Group insists dietary sodium question is settled when it plainly isn't

<乌鸦传媒>CardioBrief: You Say Potato, I Say Worthless Epidemiology

Observational study links potatoes to high blood pressure

<乌鸦传媒>Delivery at 38-39 Weeks May Be Best for Moms With Chronic HTN

More adverse outcomes seen outside this range

<乌鸦传媒>LAA Ligation as an Antihypertensive?

One study says yes, another says no

<乌鸦传媒>Blood Pressure Drop for CKD Patients on Patiromer

Sub-analyses finds those with resistant hypertension see benefits

<乌鸦传媒>ACC: TAVR Once Again Non-Inferior to Surgery

No excess stroke or mortality at 2 years in lowest risk trial population yet studied

<乌鸦传媒>ACC: HOPE Results Boost Statin Prevention Role

Mortality and nonfatal events reduced

<乌鸦传媒>Projected Uptravi Cost: $160-170K a Year

But new PAH drug is still cheaper than some alternatives

<乌鸦传媒>SPRINT v. ACCORD: Which Target Will Win in Diabetes?

Not such a no-brainer, hypertension experts say

<乌鸦传媒>Time to Retire Beta-Blockers in Uncomplicated Hypertension?

Not yet, a review of the evidence suggests

<乌鸦传媒>CardioBrief: Dollars for Heart Docs

Analysis of CMS database shows some docs pocketed millions from drug and device makers.

<乌鸦传媒>ACC: Folate Supplements Cut Strokes in Hypertension

Hypertensive patients with low blood folate levels gain big benefit.

<乌鸦传媒>Patients Should Share Accountability for Own Health

A new report recommends doctors not be penalized for poor outcomes if patients fail to follow recommended protocols

<乌鸦传媒>HTN May Halt Dementia in Very Elderly

COPENHAGEN -- Among individuals who developed hypertension at age 90 or later, their risk of also developing dementia was dramatically lower than other very elderly people whose blood pressure remained normal.

<乌鸦传媒>FDA: No Clear Sign of Harm With Olmesartan in Diabetics

The evidence linking use of the angiotensin II receptor blocker (ARB) olmesartan in patients with diabetes and increased cardiovascular risk is not conclusive, according to a completed FDA safety review.

<乌鸦传媒>Urine Test Can Uncover BP Med Adherence

A simple urine test might help clinicians figure out whether their patients aren't responding to antihypertensive therapy because of true resistance or because of nonadherence, a small study suggested.

<乌鸦传媒>How to Replace IV Nitroglycerin in the Shortage

What are the alternatives for IV nitroglycerin in the emergency setting as the shortage saps reserves? Several experts share their thoughts.

<乌鸦传媒>Early Preeclampsia Often Overlooked

Clinicians wait too long before diagnosing and treating preeclampsia, a hesitance that can be costly, according to an anesthesiologist who serves on a California preeclampsia task force.

<乌鸦传媒>Ob/Gyns Uneasy With AHA's Take on Stroke in Pregnancy

NEW ORLEANS -- Recent guidelines from the American Heart Association on the management of stroke risk in pregnant women differ significantly from those issued by the American Congress of Obstetricians and Gynecologists, maternal-fetal medicine specialists said here.

<乌鸦传媒>ACE Inhibitors Linked to Severe Allergic Reactions

BALTIMORE -- Antihypertensive treatment with ACE inhibitors may prime oral allergy syndrome patients for severe reactions, a case-report suggested.

<乌鸦传媒>Combo Angiotensin Tx Ups Kidney Risks

ATLANTA -- In yet another trial, dual blockade of the renin-angiotensin system (RAAS) didn't slow progression of kidney disease in diabetic patients and carried a higher risk of serious adverse events compared with monotherapy, researchers reported here.

<乌鸦传媒>Low BP May Be Fatal in CKD

Chronic kidney disease patients, including those with diabetes, who were not on dialysis were more likely to die when blood pressure was too low, even if only on the diastolic measure, a veterans cohort showed.

<乌鸦传媒>FDA Adds GI Warning to Benicar Label

WASHINGTON -- The FDA ordered the maker of the blood pressure drug olmesartan (Benicar) to add a warning about risk of the intestinal condition known as sprue-like enteropathy to the drug's label.

<乌鸦传媒>Honey, Cola May Disrupt Heart

A detailed history of patients with arrhythmia or syncope might need to include their cola intake or the origin of the honey they consume, two case studies suggest.

<乌鸦传媒>ACE Inhibitors Linked to Hallucinations in Elderly

Elderly patients with memory problems who suddenly have visual hallucinations may need to stop taking ACE inhibitors, researchers suggested.

<乌鸦传媒>Novel Drug Stars in Phase III PAH Trial

ATLANTA -- Macitentan, a next-generation endothelin receptor antagonist for pulmonary arterial hypertension, met its efficacy endpoint and was said to be well tolerated in a large clinical trial.

<乌鸦传媒>BP Drug Linked to Severe Diarrheal Illness

LAS VEGAS -- A patient's insightful question led to the identification of almost two dozen cases of severe enteropathy associated with use of blood pressure medication, investigators reported here.

<乌鸦传媒>Cardio Notes: Sex Improves with Stenting

Opening the arteries of those with stable coronary disease also opens the door to an improved sex life. Also this week, bariatric surgery helps remodel the heart.

<乌鸦传媒>Watchdog Group Wants Black Box on BP Meds

WASHINGTON -- The consumer watchdog group Public Citizen petitioned the FDA to add a black box warning to three classes of hypertension drugs, cautioning against their combined use.

<乌鸦传媒>Cranberry Juice May Help Lower BP a Bit

Cranberry juice modestly lowers blood pressure in healthy adults when consumed daily, a carefully controlled trial showed.

<乌鸦传媒>Doctors Say 45 Common Tests 'Overused'

Nine specialty groups have listed tests and treatments that are frequently overused, such as antibiotics for sinus attacks and CT scans for low back pain, in the first phase of a long-term project.

<乌鸦传媒>FDA Adds Diabetes Warning to Statin Label

WASHINGTON -- The FDA is changing the labeling on statins to include a warning about increased risks of hyperglycemia and transient memory problems, but the agency is no longer recommending routine liver function testing.

<乌鸦传媒>Big BP Variation Between Arms Raises Red Flag

A substantial difference in blood pressure from one arm to the other could be a warning sign for overall cardiovascular and mortality risk, a meta-analysis determined.

<乌鸦传媒>Fructose No Substitute for Glucose in Diabetes

NEW YORK -- Although it negates the dumping of glucose directly into the bloodstream, fructose may not be the choice sweetener for diabetics, researchers said here.

<乌鸦传媒>Systolic BP That's Too Low After Stroke Not Good Either

Systolic blood pressure that is too low -- as well as too high -- may put patients who have had a noncardioembolic ischemic stroke at risk for another one, researchers found.

<乌鸦传媒>High Blood Pressure May Spark Facial Nerve Pain

Patients with hypertension appear to carry a higher risk for developing trigeminal neuralgia, a Taiwanese study showed.

<乌鸦传媒>New ARB Cleared for Hypertension Treatment

The FDA has approved azilsartan medoxomil (Edarbi), an oral angiotensin II receptor blocker (ARB) for hypertension, expanding the ranks of ARBs now available to U.S. patients.

<乌鸦传媒>Common Antibiotic Linked to Elevated Potassium

Among older individuals, the commonly used antibiotic trimethoprim-sulfamethoxazole (TMP-SMX) is associated with the development of hyperkalemia requiring hospitalization, researchers found.

<乌鸦传媒>ASH: Hypertension Plus Tachycardia Equals High Risk

NEW YORK -- An elevated resting heart rate is associated with an increased risk of cardiac events in high-risk hypertension, according to a secondary analysis of a large randomized trial.

鈥�

10